Purchase Order 75N94024P00638

Award Date 8/26/24
Potential Completion Date 8/25/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
This federal contract award was made by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,385.32 firm fixed-price purchase order is for gene synthesis services to support NICHD's research activities. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that has...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to GenScript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $65,963.22 contract is for gene synthesis and related services to support NICHD's research on how transcription factors regulate gene expression and chromatin structure. The award stems from a sole-source special notice solicitation, as NICHD...
This is a federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at up to $11,500.00, was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS). The contract is a Blanket Purchase Agreement (BPA) call order, with a firm fixed-price pricing type. Through this contract, Genscript provides a wide range of molecular biology...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,141.84 purchase order to Genscript USA Inc. for "OTHER FUNCTIONS - CUSTOMIZED GENE SYNTHESES" to be performed in Bethesda, Maryland between September 8-16, 2016. As a firm fixed price contract for customized gene synthesis services, Genscript will deliver specified genetic material to the NIH organization to support its biomedical...
This federal contract award from the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, is for a Firm Fixed Price Purchase Order with Genscript USA Inc. to provide "STABLE RESEARCH CELL LINE SERVICE, INCLUDES SHIPPING CHARGES". The contract has a ceiling value of $9,885.25 and an ultimate completion date of February 28, 2011. Genscript USA Inc. is a biotechnology company that specializes in supplying...
This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $13,936.77 firm fixed price purchase order to Genscript USA Inc. for gene synthesis services. The place of performance is Bethesda, Maryland. The one-year contract runs from August 17, 2023 through August 16, 2024 to support NICHD's research programs. As a leading biotechnology company, Genscript will leverage its expertise in gene engineering to deliver customized genetic material and...
The National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, awarded a firm fixed-price purchase order contract worth $12,257.18 to Genscript USA Inc. for the provision of custom polyclonal antibodies. Genscript, a for-profit biotechnology company based in Piscataway, New Jersey, provides a range of molecular biology products and services to federal agencies, including gene synthesis, protein production, and antibody generation to...

This is a $14,500 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for NICHD laboratory services and does not have a set-aside designation.

Genscript is a provider of a wide range of molecular biology products and services to federal agencies, including gene synthesis, gene editing, custom protein and antibody production, and specialized biological materials to support biomedical research and public health initiatives. This contract award demonstrates Genscript's ongoing role as a prime contractor supporting NICHD's research activities, which may involve the delivery of customized DNA constructs, antibodies, proteins, peptides, cell lines, and related services. Genscript has also served as a subcontractor on NIH-funded research projects at academic institutions.

Generated 3/27/25, 9:52 AM